You just read:

Pharmaleads Reports Positive Ocular Pain Results with PL265, a Novel Dual Enkephalinase Inhibitor (DENKI), at the ARVO 2017 Annual Meeting

News provided by

Pharmaleads

12 May, 2017, 07:00 BST